Beta-adrenergic receptor blocking drugs in hyperthyroidism.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000503:physiopathology / Q000532:radiotherapy / Q000601:surgery; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D010096:Oxprenolol / Q000627:therapeutic use; D010869:Pindolol / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011292:Premedication; D011433:Propranolol / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use; D013566:Sympathomimetics / Q000494:pharmacology; D013965:Thyroidectomy
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D004983:Ethanolamines; D007457:Iodine Radioisotopes; D013566:Sympathomimetics; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol; D011217:Practolol